Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

• Prif Awduron: Hamdy SM (Awdur), Abdel-Naseer M (Awdur), Shehata HS (Awdur), Hassan A (Awdur), Elmazny A (Awdur), Shalaby NM (Awdur), Abokrysha NT (Awdur), Kishk NA (Awdur), Nada MAF (Awdur), Ahmed SM (Awdur), Hegazy MI (Awdur), Mekkawy D (Awdur), Mourad HS (Awdur), Abdelalim A (Awdur), Berger T (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Dove Medical Press, 2020-07-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Sherif M Hamdy,1 Maged Abdel-Naseer,1 Hatem S Shehata,1 Amr Hassan,1 Alaa Elmazny,1 Nevin M Shalaby,1 Noha T Abokrysha,1 Nirmeen A Kishk,1 Mona AF Nada,1 Sandra M Ahmed,1 Mohamed I Hegazy,1 Doaa Mekkawy,1 Husam S Mourad,1 Ahmed Abdelalim,1 Thomas Berger2 1Neurology Department, Faculty of Medicine, C...